Abbott has developed COVID-19 testing products and services
In response to the coronavirus pandemic, Abbott Laboratories (Abbott) has developed a suite of COVID-19 testing products for a variety of markets and applications. These, in order of amount of revenue generated in 2020 and 2021, include: BinaxNOW (an at home Ag Card rapid test for the US market), Panibio (a rapid antigen test for the European market), and ID NOW (a COVID-19 testing platform), among other products.
COVID|Balance Sheet|New ActivityIn response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.
Lorem Ipsum text header Report Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.